121 related articles for article (PubMed ID: 37164111)
21. Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease.
Zhang P; Liu Z; Fan H; Shi T; Han X; Suo C; Chen X; Zhang T
Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):294-301. PubMed ID: 36708301
[TBL] [Abstract][Full Text] [Related]
22. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases.
Chang Y; Cho J; Cho YK; Cho A; Hong YS; Zhao D; Ahn J; Sohn CI; Shin H; Guallar E; Ryu S
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):205-215.e7. PubMed ID: 31085337
[TBL] [Abstract][Full Text] [Related]
23. Serum cadmium is associated with hepatic steatosis and fibrosis: Korean national health and nutrition examination survey data IV-VII.
Han S; Sung GH; Lee S; Han KJ; Han HJ
Medicine (Baltimore); 2022 Jan; 101(4):e28559. PubMed ID: 35089193
[TBL] [Abstract][Full Text] [Related]
24. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease.
Zhao E; Cheng Y; Yu C; Li H; Fan X
Ann Med; 2023 Dec; 55(1):2197652. PubMed ID: 37052341
[TBL] [Abstract][Full Text] [Related]
25. Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study.
Parikh NS; Koh I; VanWagner LB; Elkind MSV; Zakai NA; Cushman M
J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105788. PubMed ID: 33866274
[TBL] [Abstract][Full Text] [Related]
26. Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta-analysis.
Yan Z; Liu Y; Li W; Zhao X; Lin W; Zhang J; Yu S; Ma J; Wang J; Yu P; Li W; Liu X
Eur J Clin Invest; 2022 Nov; 52(11):e13855. PubMed ID: 36001034
[TBL] [Abstract][Full Text] [Related]
27. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.
Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S
Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
29. Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey.
Moon JH; Koo BK; Kim W
J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):964-972. PubMed ID: 34080327
[TBL] [Abstract][Full Text] [Related]
30. FIB-4 index and liver fibrosis are risk factors for long-term outcomes in atrial fibrillation-related stroke.
Kim TH; Kim SY; Jung YK; Yim HJ; Jung JM; Seo WK
Clin Neurol Neurosurg; 2022 Jun; 217():107235. PubMed ID: 35429852
[TBL] [Abstract][Full Text] [Related]
31. Fibrosis-4 index efficiently predicts chronic hepatitis and liver cirrhosis development based on a large-scale data of general population in Japan.
Yamamichi N; Shimamoto T; Okushin K; Nishikawa T; Matsuzaki H; Yakabi S; Takahashi M; Wada R; Koike K; Fujishiro M
Sci Rep; 2022 Nov; 12(1):20357. PubMed ID: 36437271
[TBL] [Abstract][Full Text] [Related]
32. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
[TBL] [Abstract][Full Text] [Related]
33. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
[TBL] [Abstract][Full Text] [Related]
34. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease.
Park H; Yoon EL; Ito T; Jo AJ; Kim M; Lee J; Kim HL; Arai T; Atsukawa M; Kawanaka M; Toyoda H; Ishigami M; Yu ML; Jun DW; Nguyen MH
JAMA Netw Open; 2023 Aug; 6(8):e2329568. PubMed ID: 37589973
[TBL] [Abstract][Full Text] [Related]
36. FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.
So-Armah KA; Lim JK; Lo Re V; Tate JP; Chang CH; Butt AA; Gibert CL; Rimland D; Marconi VC; Goetz MB; Ramachandran V; Brittain E; Long M; Nguyen KL; Rodriguez-Barradas MC; Budoff MJ; Tindle HA; Samet JH; Justice AC; Freiberg MS;
Prog Cardiovasc Dis; 2020; 63(2):184-191. PubMed ID: 32068085
[TBL] [Abstract][Full Text] [Related]
37. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis.
Jung CH; Rhee EJ; Kwon H; Chang Y; Ryu S; Lee WY
Endocrinol Metab (Seoul); 2020 Mar; 35(1):165-176. PubMed ID: 32207277
[TBL] [Abstract][Full Text] [Related]
38. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.
Wong RJ; Liu B; Bhuket T
Aliment Pharmacol Ther; 2017 Nov; 46(10):974-980. PubMed ID: 28914448
[TBL] [Abstract][Full Text] [Related]
39. Validation of P2/MS and other noninvasive fibrosis scoring systems in the Korean population with nonalcoholic fatty liver disease.
Yu SJ; Kim DH; Lee JH; Chung GE; Yim JY; Park MJ; Kim YJ; Yoon JH; Jang JJ; Lee HS
Korean J Gastroenterol; 2011 Jan; 57(1):19-27. PubMed ID: 21258197
[TBL] [Abstract][Full Text] [Related]
40. Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999-2016.
Lee CO; Li HL; Tsoi MF; Cheung CL; Cheung BMY
Ann Med; 2021 Dec; 53(1):1065-1073. PubMed ID: 34184611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
